Latest News

Study Tests New Breast Cancer Drug in African American Women
The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.

Precision Medicine Clinical Trial for Metastatic Pancreatic Cancer Now Open at Georgetown Lombardi
The first clinical trial to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer is now enrolling patients at Georgetown Lombardi Comprehensive Cancer Center.

Immunotherapy Research Expands to Include Rare Cancer
In 2013 at the age of 53, Semple, a healthy trialthlete, was diagnosed with advanced cancer of the thymus, a small gland in the neck that produces T cells for the immune system.